Search filters

List of works by Norbert Gattermann

A retrospective study evaluating the impact of infectious complications during azacitidine treatment

scientific article published on 4 May 2017

Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia

scientific article

Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cells

scientific article published on 04 July 2007

Anaesthesia in a patient with subarachanoidal haemorrhage and high oxygen affinity haemoglobinopathy (HB york): case report

scientific article

Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes

scientific article published on 01 May 2008

Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement

scientific article published on 09 April 2007

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

scientific article

Causes of death in 2877 patients with myelodysplastic syndromes

scientific article

Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes

scientific article

Chronic myelomonocytic leukemia in the light of the WHO proposals

scientific article published on 01 July 2007

Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial

scientific article published on 21 December 2018

Clinical Spectrum of Primary Adrenal Lymphoma: Results of a Multicenter Cohort Study

scientific article published on 01 June 2020

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

scientific article

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

scientific article published on 10 January 2011

Correspondence (reply): In Reply

Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis

scientific article

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

scientific article published on 6 May 2010

Deferasirox treatment of iron‐overloaded chelation‐naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange ⬇️

scientific article published on November 24, 2011

Diagnosis and Therapy of Myelodysplastic Syndromes in Germany: A Retrospective Multicenter Analysis ⬇️

scientific article published on May 25, 2012

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

scientific article published on 26 August 2013

Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes

scientific article published on 01 August 2010

Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome

scientific article published on 20 January 2009

Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia

scientific article

Do Recent Randomized Trial Results Influence which Patients with Myelodysplastic Syndromes Receive Iron Chelation?

scientific article published on 21 January 2020

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

scientific article published on 22 February 2018

Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia

scientific article

Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial

scientific article published on 19 May 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

scientific article

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.

scientific article

Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes ⬇️

scientific article published on March 13, 2012

Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis

scientific article published on 26 December 2007

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

scientific article (publication date: 7 December 2006)

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells

scientific article

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays

scientific article published on 27 May 2008

Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias

scientific article published on 12 July 2012

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

scientific article published on December 2007

Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions

scientific article published on 10 June 2019

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes ⬇️

scientific article published on March 14, 2012

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

scientific article published on 01 February 2007

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

scientific article published on 15 December 2008

How to treat MDS without stem cell transplantation

scientific article published on 24 October 2009

Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes

scientific article published on 31 January 2011

Imatinib in breast milk.

scientific article

Impact on survival of different treatments for myelodysplastic syndromes (MDS).

scientific article published on 30 January 2009

Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes

scientific article published on 14 February 2015

Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes

scientific article

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

scientific article published on 03 August 2020

Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry ⬇️

scientific article published on 06 May 2012

Improving the accuracy of prognostication in chronic myelomonocytic leukemia

scientific article published on 23 July 2020

In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time

scientific article published on 11 May 2015

Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry

scientific article published on June 25, 2011

Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome ⬇️

scientific article published on October 23, 2003

Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes

scientific article published on 01 July 2007

Iron overload in MDS-pathophysiology, diagnosis, and complications

scientific article published on 12 October 2010

Iron overload in myelodysplastic syndromes (MDS).

scientific article published on 25 November 2017

Iron rusting in the mitochondria?

scientific article published on 01 October 2016

Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia

scientific article published on 18 July 2008

Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy

scientific article published on 04 August 2018

Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

scientific article published on 09 August 2019

Mastering the multitude of monocytoses

Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes

scientific article published on 16 January 2009

Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia

scientific article published in June 2009

Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations

scientific article

Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromes

scientific article published on 25 July 2019

Myelodysplastic syndromes

scientific article published on 01 January 2002

Myelodysplastic syndromes (MDS) in regular care in Germany - the oldest patients come to the fore

scientific article published on 15 September 2017

Myelodysplastic syndromes in patients younger than age 50

scientific article published on 06 November 2006

Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany

scientific article published on 31 July 2008

Myelodysplastic syndromes: diagnosis, prognosis, and treatment

scientific article

Neut-X can be successfully used as diagnostic and prognostic tool in MDS

scientific article published on 13 September 2019

New Trends in Iron Chelation: Impacting Outcomes

New insights into transfusion-related iron toxicity: Implications for the oncologist

scientific article

New prognostic parameters for chronic myelomonocytic leukemia

scientific article published on 01 July 2002

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types

scientific article published on 27 February 2017

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value ⬇️

scientific article published on August 6, 2010

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

scientific article

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

scientific article

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis

scientific article

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

scientific article published on 22 November 2010

No increase in age-specific incidence of myelodysplastic syndromes

scientific article published on 01 August 2004

Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.

scientific article

Novel therapies in low- and high-risk myelodysplastic syndrome

scientific article published on 31 July 2019

Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLC

scientific article published on 10 January 2006

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

scientific article published on 27 June 2008

Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS ⬇️

scientific article published on January 1, 2012

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

scientific article

Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion

scientific article published on 06 July 2010

Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome

scientific article published on 06 April 2007

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes

scientific article published on 18 July 2007

Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

scientific article published on 05 February 2010

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes

scientific article

Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation

scientific article published in January 2003

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

scientific article

Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.

scientific article

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals

scientific article

Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

scientific article

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning

scientific article published in November 2002

Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine

scientific article published on 17 March 2009

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

scientific article published in December 2005

SF3B1 and the riddle of the ring sideroblast ⬇️

scientific article published on October 18, 2012

Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7

scientific article published on 01 May 2005

Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome ⬇️

scientific article published on July 11, 2013

Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease

scholarly article

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

scientific article

Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide

scientific article published on 21 September 2015

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

scientific article

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

scientific article published on 31 March 2009

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia

scientific article

The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany

scientific article

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

scientific article published on 24 January 2014

The treatment of secondary hemochromatosis

scientific article published on 24 July 2009

Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study

scientific article published in December 2008

Therapy-related myeloid neoplasms following treatment with radioiodine ⬇️

scientific article published on October 11, 2011

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

scientific article

Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid ⬇️

scientific article published on April 8, 2011

Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations

scientific article published on 20 June 2015

Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts

scientific article

Valproic acid for the treatment of myeloid malignancies

scientific article published on September 2007

When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?

scientific article published on October 2013

X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns

scientific article (publication date: 2006)

γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm

scientific article published on May 2016

Paulina is supported by:

About Paulina

Help